4- (4-bromo-2-fluoroanilino) - 6-methoxy-7- (l-methylpiperidin-4 - ylmethoxy) quinazoline momohydrate

Details for Australian Patent Application No. 2006296371 (hide)

Owner AstraZeneca AB

Inventors Meyrick, Brian Roger; Booth, Rebecca Jane; Patel, Zakariya; Storey, Richard Anthony

Agent Davies Collison Cave

Pub. Number AU-A-2006296371

PCT Pub. Number WO2007/036717

Priority 0519878.3 30.09.05 GB

Filing date 27 September 2006

Wipo publication date 5 April 2007

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/036717 Priority application(s): WO2007/036717

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006296381-Condensed pyrazole derivatives as PPAR agonists II

2006296369-Compounds which have activity at M1 receptor and their uses in medicine